Mixed Spice Capsules for Memory in Age-related Cognitive Decline
Mixed spices
+ Placebo
Prevention Study
Summary
Study start date: February 21, 2025
Actual date on which the first participant was enrolled.This study investigates whether consuming a mix of spices can improve memory in middle-aged and older adults experiencing normal age-related memory decline. As people age, changes in the brain can lead to slower thinking and memory issues. Some spices are thought to help protect memory, and this study explores if a combination of these spices is more effective than using just one. The study aims to find out if regular intake of these spices can help maintain brain health and support better memory, potentially offering new dietary advice for older adults. Participants in the study are between 50 and 80 years old and do not have dementia or major memory disorders. They are randomly assigned to take either spice capsules or placebo capsules made of maltodextrin for three months, followed by an additional three-month observation period. The study measures changes in memory, energy levels, and mood to see if the spice mixture has any impact. By evaluating antioxidant and anti-inflammatory properties of the spices, this research seeks to provide insights into how spices might help preserve cognitive function in aging populations.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 50 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: 1. Participants are required to have clinical histories consistent with normal aging or mild cognitive impairment (MCI). 2. Age 50 to 80 years. 3. Adequate visual acuity and hearing to allow neuropsychological testing. 4. Screening laboratory tests without significant abnormalities that might interfere with the study. \- Exclusion Criteria: 1. Diagnosis of probable Alzheimer's disease or any other dementia (e.g. vascular, Lewy body, frontotemporal) 2. Evidence of other neurological or physical illness that can produce cognitive deterioration. Determination of dementia will be based on the clinical evaluation including assessment of functional abilities, and cognitive screening (using the Mini Mental State Examination 3. Evidence of Parkinson's disease as determined by the motor examination (items 18-31) of the Unified Parkinson's Disease Rating Scale \[38\]. 4. Uncontrolled hypertension (systolic blood pressure (BP) \> 170 or diastolic BP \> 100). 5. Consume spices regularly \> 5g day 6. Allergy or sensitivity to spices. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive history of spices ingestion without incident will be requested. In addition, any subject with a history of allergy or anaphylaxis of any kind will be excluded. 7. Current diagnosis of any major psychiatric disorder according to the DSM-IV TR criteria (APA, 2000). 8. Current diagnosis or alcoholism or substance addiction. 9. Eating a high fiber/polyphenol diet or taking any medication or dietary supplement which interfere with the absorption of polyphenols. 10. Frequently using prebiotics, probiotics, yogurt, and/or any fiber supplements
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
UCLA Center for Human Nutrition
Los Angeles, United StatesOpen UCLA Center for Human Nutrition in Google Maps